Women with Mesothelioma Have Better Odds than Men
Women who are diagnosed with malignant pleural mesothelioma usually have better odds of survival than men. This was one of…
Understanding Sarcomatoid Mesothelioma
Mesothelioma is a cancer that is difficult to diagnose and treat. Sarcomatoid mesothelioma is the most aggressive type of mesothelioma.…
Radiotherapy Outcomes in Mesothelioma Linked to Pembrolizumab
Canadian researchers say radiotherapy may hold the key to improving outcomes in mesothelioma. Mesothelioma is a fast-growing membrane cancer caused…
Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
Mesothelioma Surveillance Protocols, Quality of Life, and Patient Hope
Mesothelioma surveillance protocols are a series of medical tests. Surveillance is designed to detect and track cancer progression. Surveillance protocols…
Australia | Diagnosis | Genetics | International | Mesothelioma | Research
Genetic Mesothelioma Risk May Lead to Shorter Latency
A particular genetic risk for mesothelioma may be behind the few cases where cancer develops just a few years after…
New Mesothelioma Grading System: A Better Path to Prognosis?
A team of Australian researchers have developed a new mesothelioma grading system they believe is a more accurate method for…
Mesothelioma Clinical Trials: Eligibility May Be Too Strict, Study Finds
A new Australian study suggests that too many people are being left out of mesothelioma clinical trials under current trial…
Exercise Unlikely to Prevent Mesothelioma Development
A new Australian study suggests that exercise is unlikely to prevent mesothelioma development in people who have been exposed to…
Immune Checkpoint Inhibitor May Change the Standard Treatment of Malignant Pleural Mesothelioma
The immune checkpoint inhibitor durvalumab could become a standard part of first-line mesothelioma treatment if the results of a new…